July 01, 2025

Retinal Thickness Patterns Linked to ALS Risk

In a long-term cohort study, researchers found that specific retinal changes—thinner photoreceptor layers and thicker retinal pigment epithelium—were linked to a higher risk of developing amyotrophic lateral sclerosis, suggesting potential noninvasive biomarkers for early detection.

Conexiant

June 20, 2025

Foundation Fighting Blindness Submits Testimony to Congress for NEI Funding

The testimony urged US Senate subcommittee to deliver strong, sustained funding for the NEI and maintain the NEI’s status as an independent NIH institute in the FY2026 appropriations cycle.

Optometric Management

June 20, 2025

Retinal Changes Linked to Neurological Disease Progression

New research reviewed dozens of studies and revealed that visual dysfunction, including retinal changes, may serve as early signs of neurodegenerative and neurodevelopmental diseases, offering a noninvasive pathway for earlier diagnosis and disease monitoring.

Conexiant

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant

June 17, 2025

FDA Clears IND Amendment to Initiate Phase 2/3 Trial of Ocugen's OCU410ST for Stargardt Disease

The phase 2/3 clinical trial for OCU410ST, a modifier gene therapy candidate, will enroll 51 participants diagnosed with Stargardt disease. The primary objective of the trial is to evaluate the reduction in atrophic lesion size.

Ophthalmology Management

March 07, 2025

OCT-A Finds Decrease in Retinal Capillary Perfusion in Patients With Long COVID

Retinal structural integrity remained preserved.

Conexiant

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician

May 20, 2025

A View of the Cellview

Exploring the features and benefits of a new retinal imaging system

The Ophthalmologist

July 01, 2023

GA THERAPIES ON THE WAY

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Ophthalmology Management